• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颅内脑膜瘤,世界卫生组织二级:临床病理特征的预后意义

Intracranial Meningiomas, WHO Grade Il : Prognostic Implications of Clinicopathologic Features.

作者信息

Moon Hyung-Sik, Jung Shin, Jang Woo-Youl, Jung Tae-Young, Moon Kyung-Sub, Kim In-Young

机构信息

Department of Neurosurgery, Chonnam National University Research Institute of Medical Sciences, Chonnam National University Hwasun Hospital & Medical School, Gwangju, Korea.

出版信息

J Korean Neurosurg Soc. 2012 Jul;52(1):14-20. doi: 10.3340/jkns.2012.52.1.14. Epub 2012 Jul 31.

DOI:10.3340/jkns.2012.52.1.14
PMID:22993672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3440497/
Abstract

OBJECTIVE

Intracranial meningiomas are primarily benign tumors with a good prognosis. Although WHO grade II meningiomas are rare (2-10%), WHO grade II meningiomas have higher recurrence and mortality rates than benign. We evaluated the patient recurrence rate and investigated the prognostic factors of WHO grade II meningiomas.

METHODS

Between 1993 and 2005, 55 patients were diagnosed with WHO grade II meningiomas in our hospital. WHO grade II meningiomas (n=55) were compared with other WHO grades meningiomas (I, n=373; and III, n=20). The patients had a median age of 48.4 years (range, 14-17 years), a male-to-female ratio of 26 : 29, and a mean follow-up time of 45 months (range, 3-175 months).

RESULTS

In WHO grade II meningiomas, only the extent of resection was a significant prognostic factor. Post-operative radiotherapy had no significant influence on tumor recurrence (p=0.053). The relative risk of recurrence was significantly higher in WHO grade II meningiomas with incomplete resection (10/27, RR=37%) than in WHO grade II meningiomas with complete resection (4/28, RR=14%) regardless of post-operative radiotherapy. In the incomplete resection group, Simpson grade III or IV had a significantly high risk of recurrence regardless of post-operative RT (n=3, RR=100%) However, if the degree of resection was Simpson grade II, the recurrence rate was similar to the complete resection group even though post-operative RT was not performed.

CONCLUSION

Complete resection was the most powerful independent predictive factor of the recurrence rate in WHO grade II meningiomas. Post-operative adjuvant RT was not a significant factor in this study.

摘要

目的

颅内脑膜瘤主要是良性肿瘤,预后良好。虽然世界卫生组织(WHO)二级脑膜瘤很少见(2%-10%),但其复发率和死亡率高于良性脑膜瘤。我们评估了患者的复发率,并研究了WHO二级脑膜瘤的预后因素。

方法

1993年至2005年期间,我院有55例患者被诊断为WHO二级脑膜瘤。将WHO二级脑膜瘤(n=55)与其他WHO级别的脑膜瘤(I级,n=373;III级,n=20)进行比较。患者的中位年龄为48.4岁(范围14-17岁),男女比例为26:29,平均随访时间为45个月(范围3-175个月)。

结果

在WHO二级脑膜瘤中,只有切除范围是一个重要的预后因素。术后放疗对肿瘤复发没有显著影响(p=0.053)。无论术后是否放疗,WHO二级脑膜瘤不完全切除患者的复发相对风险(10/27,RR=37%)显著高于完全切除患者(4/28,RR=14%)。在不完全切除组中,无论术后是否放疗,辛普森III级或IV级的复发风险显著较高(n=3,RR=100%)。然而,如果切除程度为辛普森II级,即使未进行术后放疗,复发率也与完全切除组相似。

结论

完全切除是WHO二级脑膜瘤复发率最有力的独立预测因素。在本研究中,术后辅助放疗不是一个显著因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e2/3440497/146e66343a15/jkns-52-14-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e2/3440497/e32a3666cfec/jkns-52-14-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e2/3440497/146e66343a15/jkns-52-14-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e2/3440497/e32a3666cfec/jkns-52-14-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e2/3440497/146e66343a15/jkns-52-14-g002.jpg

相似文献

1
Intracranial Meningiomas, WHO Grade Il : Prognostic Implications of Clinicopathologic Features.颅内脑膜瘤,世界卫生组织二级:临床病理特征的预后意义
J Korean Neurosurg Soc. 2012 Jul;52(1):14-20. doi: 10.3340/jkns.2012.52.1.14. Epub 2012 Jul 31.
2
Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes.具有非典型组织学特征的良性脑膜瘤(世界卫生组织一级):组织病理学特征与临床结果的相关性
J Neurosurg. 2016 Jan;124(1):106-14. doi: 10.3171/2015.1.JNS142228. Epub 2015 Aug 14.
3
Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.术后放疗对原发性颅内非典型脑膜瘤复发的影响。
J Neurooncol. 2020 Jan;146(2):347-355. doi: 10.1007/s11060-019-03382-x. Epub 2020 Jan 3.
4
Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry.WHO 分级 II 级和 III 级颅内脑膜瘤的辅助放疗:来自国家癌症登记处的生存和实践模式的见解。
J Neurooncol. 2020 Sep;149(2):293-303. doi: 10.1007/s11060-020-03604-7. Epub 2020 Aug 28.
5
Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.非典型脑膜瘤的长期生存分析:生存率、预后因素、手术及放射治疗
Acta Neurochir (Wien). 2014 Aug;156(8):1475-81. doi: 10.1007/s00701-014-2156-z. Epub 2014 Jun 26.
6
Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma.Simpson 分级系统与世界卫生组织一级脑膜瘤手术后无复发生存的相关性。
J Neurosurg. 2017 Jan;126(1):201-211. doi: 10.3171/2016.1.JNS151842. Epub 2016 Apr 8.
7
Post Surgical Management of WHO Grade II Meningiomas: Our Experience, the Role of Gamma Knife and a Literature Review.世界卫生组织二级脑膜瘤的术后管理:我们的经验、伽玛刀的作用及文献综述
Life (Basel). 2022 Dec 23;13(1):37. doi: 10.3390/life13010037.
8
Oncologic benefits of dural resection in spinal meningiomas: a meta-analysis of Simpson grades and recurrence rates.脊髓脑膜瘤硬脑膜切除术的肿瘤学益处:辛普森分级与复发率的荟萃分析
J Neurosurg Spine. 2019 Nov 8;32(3):441-451. doi: 10.3171/2019.8.SPINE19859. Print 2020 Mar 1.
9
Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series.颅内脑膜瘤:对一个大型单机构手术系列中复发预后因素的系统分析
World Neurosurg. 2019 Mar;123:e273-e279. doi: 10.1016/j.wneu.2018.11.150. Epub 2018 Nov 26.
10
Clinical Features, Treatment, and Prognostic Factors of 56 Intracranial and Intraspinal Clear Cell Meningiomas.56例颅内和脊髓内透明细胞型脑膜瘤的临床特征、治疗及预后因素
World Neurosurg. 2018 Mar;111:e880-e887. doi: 10.1016/j.wneu.2017.12.173. Epub 2018 Jan 8.

引用本文的文献

1
Management of intracranial meningioma: Outcome analysis and clinico radiological profile of 172 patients.颅内脑膜瘤的治疗:172例患者的疗效分析及临床影像学特征
Surg Neurol Int. 2024 Dec 13;15:464. doi: 10.25259/SNI_556_2024. eCollection 2024.
2
Surgical Management of High-Grade Meningiomas.高级别脑膜瘤的外科治疗
Cancers (Basel). 2024 May 23;16(11):1978. doi: 10.3390/cancers16111978.
3
Is DNA Methylation a Ray of Sunshine in Predicting Meningioma Prognosis?DNA甲基化能否成为预测脑膜瘤预后的一线曙光?

本文引用的文献

1
Radiotherapy as an adjuvant in the management of intracranial meningiomas: are we practising evidence-based medicine?放射治疗作为颅内脑膜瘤治疗的辅助手段:我们是在践行循证医学吗?
Br J Neurosurg. 2008 Aug;22(4):520-8. doi: 10.1080/02688690802308687.
2
Atypical meningiomas: WHO moved the goalposts?非典型脑膜瘤:世界卫生组织改变标准了吗?
Br J Neurosurg. 2007 Dec;21(6):588-92. doi: 10.1080/02688690701684246.
3
Intracranial meningiomas: an overview of diagnosis and treatment.颅内脑膜瘤:诊断与治疗概述
Front Oncol. 2020 Sep 4;10:1323. doi: 10.3389/fonc.2020.01323. eCollection 2020.
4
A gene expression signature predicts recurrence-free survival in meningioma.一种基因表达特征可预测脑膜瘤的无复发生存率。
Oncotarget. 2018 Feb 15;9(22):16087-16098. doi: 10.18632/oncotarget.24498. eCollection 2018 Mar 23.
5
Recurred Intracranial Meningioma: A Retrospective Analysis for Treatment Outcome and Prognostic Factor.复发性颅内脑膜瘤:治疗结果与预后因素的回顾性分析
Brain Tumor Res Treat. 2017 Oct;5(2):54-63. doi: 10.14791/btrt.2017.5.2.54. Epub 2017 Nov 3.
6
Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma.全球表观遗传学分析确定了与脑膜瘤无复发生存相关的甲基化亚组。
Acta Neuropathol. 2017 Mar;133(3):431-444. doi: 10.1007/s00401-017-1678-x. Epub 2017 Jan 27.
7
WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment.世界卫生组织二级脑膜瘤:一项关于预后及预后因素评估的回顾性研究。
J Neurooncol. 2016 Sep;129(2):337-45. doi: 10.1007/s11060-016-2181-2. Epub 2016 Jun 16.
8
Factors Associated with Low Socioeconomic Status Predict Poor Postoperative Follow-up after Meningioma Resection.与社会经济地位低下相关的因素预示着脑膜瘤切除术后随访效果不佳。
J Neurol Surg B Skull Base. 2016 Jun;77(3):226-30. doi: 10.1055/s-0035-1566122. Epub 2015 Oct 28.
9
Epigenetic Role of Histone 3 Lysine Methyltransferase and Demethylase in Regulating Apoptosis Predicting the Recurrence of Atypical Meningioma.组蛋白3赖氨酸甲基转移酶和去甲基化酶在调节细胞凋亡中预测非典型脑膜瘤复发的表观遗传学作用
J Korean Med Sci. 2015 Aug;30(8):1157-66. doi: 10.3346/jkms.2015.30.8.1157. Epub 2015 Jul 15.
10
Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.有丝分裂指数是脑膜瘤无复发生存的独立预测指标。
Brain Pathol. 2015 May;25(3):266-75. doi: 10.1111/bpa.12174. Epub 2014 Oct 29.
Neurosurg Focus. 2007;23(4):E1. doi: 10.3171/FOC-07/10/E1.
4
The 2007 WHO classification of tumours of the central nervous system.2007年世界卫生组织中枢神经系统肿瘤分类
Acta Neuropathol. 2007 Aug;114(2):97-109. doi: 10.1007/s00401-007-0243-4. Epub 2007 Jul 6.
5
Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.非典型和恶性脑膜瘤的管理:大剂量三维适形放射治疗的作用
J Neurooncol. 2000 Jun;48(2):151-60. doi: 10.1023/a:1006434124794.
6
Recurrence of meningiomas.脑膜瘤复发
Cancer. 2000 Sep 1;89(5):1102-10. doi: 10.1002/1097-0142(20000901)89:5<1102::aid-cncr20>3.0.co;2-l.
7
Local control and overall survival in atypical meningioma: a retrospective study.非典型脑膜瘤的局部控制和总生存率:一项回顾性研究。
Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):57-61. doi: 10.1016/s0360-3016(99)00349-1.
8
Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis.
Acta Neurochir (Wien). 1999;141(9):921-32. doi: 10.1007/s007010050398.
9
Predicting the probability of meningioma recurrence based on the quantity of peritumoral brain edema on computerized tomography scanning.基于计算机断层扫描上肿瘤周围脑水肿量预测脑膜瘤复发的概率。
J Neurosurg. 1999 Sep;91(3):375-83. doi: 10.3171/jns.1999.91.3.0375.
10
Preoperative identification of meningiomas that are highly likely to recur.
J Neurosurg. 1999 Mar;90(3):455-62. doi: 10.3171/jns.1999.90.3.0455.